BACKGROUND: Biochemical control from series in which radical prostatectomy is performed for patients with unfavorable prostate cancer and/or low dose external beam radiation therapy are given remains suboptimal.
The treatment regimen of HDR brachytherapy and external beam radiotherapy is a safe and very effective treatment for patients with high risk localized prostate cancer with excellent biochemical control and low toxicity.
Written by:
Prada PJ, Mendez L, Fernández J, González H, Jiménez I, Arrojo E. Are you the author?
Department of Radiation Oncology, Hospital Universitario Central de Asturias, Oviedo, Spain.
Reference: Radiat Oncol. 2012 Mar 7;7:31.
doi: 10.1186/1748-717X-7-31
PubMed Abstract
PMID: 22397528
UroToday.com Prostate Cancer Section